CAPHRA Calls for Review of Tobacco Harm Reduction Methods

Dec.13.2022
CAPHRA Calls for Review of Tobacco Harm Reduction Methods
The CAPHRA coalition sent a letter to FCTC representatives urging them to review THR methods for COP10 in Panama.

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), which comprises of nine member organizations, has written to chiefs of delegations of the Framework Convention on Tobacco Control (FCTC) worldwide, urging them to review methods supporting the reduction of tobacco harm (THR).


As governments from various countries send representatives to attend the 10th Conference of the Parties (COP10) in November 2023, the CAPHRA Alliance is eager to provide comprehensive reference materials to leaders for COP10 planning, submission and deliberation.


The 10th Conference of the Parties (COP10) will be held in Panama and hosted by the World Health Organization's Framework Convention on Tobacco Control.


We represent four million nicotine product users in the Asia-Pacific region. Our region is particularly vulnerable to the dangers and deaths caused by combustible and unsafe oral tobacco worldwide," the letter stated.


Representatives from the CAPHRA alliance have reminded health leaders that the FCTC convention has the authority to consider harm reduction as a core tobacco control policy.


For decades, it has been widely known that the tar and carcinogens found in tobacco smoke lead to smoking-related deaths and illnesses, rather than nicotine. Studies have shown that although nicotine is generally mildly addictive, like caffeine, it is not a health concern, they wrote.


The letter also calls on representatives to condemn the policy of holding the COP10 conference behind closed doors by the FCTC.


They wrote: "COP10 should represent the rights and wishes of the citizens. Their participation fees are paid by taxpayers and it is hoped that they speak for themselves, recognize the scientific benefits of supporting ENDS for harm reduction, and uphold democratic principles," they wrote.


Representatives of the CAPHRA Alliance are requesting that countries take into account consumers' right to make choices that help them avoid negative health outcomes when submitting their COP10 submissions. Additionally, smokers have the right to access nicotine products with lower harm as alternatives to smoking.


A recent white paper titled "Disrupting Public Health: A Consumer Perspective" was presented by Nancy Loucas, the executive coordinator of the CAPHRA alliance, at the 5th Asia Harm Reduction Forum. The evidence-based document was included in the presentation.


2FIRSTS will continue to cover this issue, with updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group A/S has issued notice of its annual general meeting, which will be held on April 15, 2026 at 4:30 p.m. in Copenhagen and will also be available by live webcast.
Mar.25 by 2FIRSTS.ai
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium’s federal government on Thursday approved a ban on flavored vapes, allowing only tobacco-flavored and unflavored e-cigarettes on the market from September 2028. Health Minister Frank Vandenbroucke said the measure is aimed at protecting the health of children and young people and preventing a new generation from becoming dependent on tobacco.
May.06 by 2FIRSTS.ai
Russia Moves Toward Full Ban on E-Cigarettes and Vapes, With Scope Still Under Discussion
Russia Moves Toward Full Ban on E-Cigarettes and Vapes, With Scope Still Under Discussion
Russia’s State Commission for Countering Illegal Trafficking in Industrial Products on March 25 supported an initiative to fully ban the production, import and circulation of electronic cigarettes, vapes and refill liquids in Russia.
Mar.26 by 2FIRSTS.ai
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
The Tasmanian government has tabled the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026 in Parliament, proposing new offences, higher penalties and stronger enforcement powers to crack down on illicit tobacco and vaping products.
Mar.25 by 2FIRSTS.ai
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13